Loading…

Loading grant details…

Completed HORIZON European Commission

Novel bio-inspired energy harvesting and storage all-in-one platform for implantable devices based on peptide nanotechnology


Funder European Commission
Recipient Organization Tel Aviv University
Country Israel
Start Date Dec 01, 2022
End Date Nov 30, 2024
Duration 730 days
Number of Grantees 2
Roles Coordinator; Participant
Data Source European Commission
Grant ID 101101071
Grant Description

Over the past decades, implantable biomedical systems have greatly advanced, offering previously unavailable therapeutic options for millions of patients worldwide. Such applications most commonly utilize conventional lithium-ion batteries as the energy source.

However, while readily providing adequate energetic performance, lithium-ion batteries are inflexible, rigid, may contain toxic substances, and require periodic replacement surgeries due to their limited capacity, posing both health risks and an economical burden.

Here, aiming to address these issues, we will develop PepZoPower, a biocompatible energy harvesting, and storage device designed for biomedical applications.

Energy harvesting will be facilitated by highly-efficient piezoelectric peptide-based assemblies allowing to harvest mechanical energy from the human body and convert it into electric energy.

The harvested mechanical energy will be stored by a biocompatible peptide-based supercapacitor, thus giving rise to an autonomous, miniaturized, controllable, and biocompatible power device with adequate performance and mechanical properties.

This ambitious goal will be achieved by utilizing our patent-protected piezoelectric and energy storage peptide-based supramolecular structures, to be incorporated into an integrated device.

The performance of each layer will be optimized and the integrated PepZoPower device will be validated to verify efficient incorporation of the two components.

We envision the breakthrough PepZoPower technology to serve as the basis for the next leap toward biocompatible, soft, miniaturized, light-weight and morphologically-controllable implantable devices.

This will pave the way towards post-project commercial exploitation of the PepZoPower system, which will be further developed by a spin-off company to be integrated into implantable devices ranging from cardiac defibrillators to spinal cords stimulators, opening a huge market opportunity for this radically new technology.

All Grantees

Tel Aviv University; Day One Societa A Responsabilita Limitata

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant